Vilnius, Lithuania – Landing Med’s Founder and Chairwoman, Dr. Xiaorong Sun, was honored to be invited to speak at the prestigious European Congress of Digital and Spatial Pathology (ECDP) in Vilnius, Lithuania, marking a milestone for the company’s global presence in digital pathology.
Landing Med was the only Chinese organization invited to present at the congress, underscoring the company’s leadership in advancing medical technology. Dr. Sun's presentation focused on the world’s first large-scale cervical cancer screening program implemented across millions of women in China, which garnered significant attention and praise from global leaders in pathology.
The Hubei Provincial Population-Based AI Cervical Cancer Screening Program, powered by Landing Med's AI-driven digital pathology technologies, has made remarkable strides in improving early detection and screening efficiency. Through partnership with multiple government organizations, the program has reached 6+ million women across the province thus far. The results have shown increased screening participation, earlier detection rates, and more efficient diagnoses, demonstrating the program’s potential for saving lives and transforming public health outcomes.
Dr. Sun’s presentation highlighted how AI-powered technology has enabled a scalable and efficient approach to cervical cancer screening, while also showcasing the broader impact of digital pathology in addressing China’s severe shortage of pathologists. Her insights impressed many global pathology experts, with numerous discussions following the session on the scalability and impact of Landing Med’s model in other parts of the world.
Landing Med’s participation at the ECDP further solidifies the company’s role as a global leader in digital pathology and AI-based diagnostic solutions, and underscores its commitment to improving global healthcare through innovation, collaboration, and accessible medical technologies.
CN
